Trials / Terminated
TerminatedNCT00496171
Phase I Study of HAL Formulations Applied to the Cervix in Healthy Volunteers
A Phase I Hexaminolevulinate (HAL) Dose-Finding Study Applying Different Formulations to the Cervix in Healthy Volunteers
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- —
- Sponsor
- Photocure · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to determine the most effective formulation of HAL for release of hexaminolevulinate to the cervical epithelium at different doses.
Conditions
Timeline
- First posted
- 2007-07-04
- Last updated
- 2009-01-16
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT00496171. Inclusion in this directory is not an endorsement.